Secondly, Ozempic suppresses glucagon release , a hormone that raises blood sugar by prompting the liver to release stored glucose
The number of studies investigating KD in pregnant women is still too low to conclusively determine the diets effect on the course of pregnancy
Patients with severe kidney disease (eGFR below 2030) Patients with recurrent UTIs or fungal infections Type 1 diabetes patients (unless specifically prescribed) Pregnant women References: Protective Influence of SGLT-2 Inhibitors Against Heart Failure PMC 2024 Clinical Evidence for Cardiovascular & Kidney Benefits PMC SGLT2 Inhibitors: Antidiabetic and Cardioprotective Effects PMC Emerging Horizons: SGLT-2 Inhibitors Beyond Diabetes PMC DPP-4 inhibitors, sulfonylureas, TZDs So far we have covered the star players Metformin, GLP-1 agonists, and SGLT2 inhibitors
Other options could be dermal treatments
Willis M, Asseburg C, Nilsson A, Johnsson K, Kartman B